Deoxycytidine (dCyd) kinase is required for the phosphorylation of several deoxyribonucleosides and certain nucleoside analogs widely employed as antiviral and chemotherapeutic agents. Detailed analysis of this enzyme has been limited, however, by its low abundance and instability. Using oligonudeotides based on primary amino acid sequence derived from purified dCyd kinase, we have screened T-lymphoblast cDNA libraries and identified a cDNA sequence that encodes a 30.5-kDa protein corresponding to the subunit molecular mass of the purified protein. Expression ofthe cDNA in Escherichia coli results in a 40-fold increase in dCyd kinase activity over control levels. In dCyd kinase-deficient murine L cells, transfection with dCyd kinase cDNA in a mammalian expression vector produces a 400-fold increase over control in dCyd phosphorylating activity. The expressed enzyme has an apparent K. of 1.0 FM for dCyd and is also capable of phosphorylating dAdo and dGuo. Northern blot analysis reveals a single 2.8-kilobase mRNA expressed in T lymphoblasts at 5-to 10-fold higher levels than in B lymphoblasts, and decreased dCyd kinase mRNA levels are present in T-lymphoblast cell lines resistant to arabinofuranosylcytosine and dideoxycytidine. These rindings document that this cDNA encodes the T-lymphoblast dCyd kinase responsible for the phosphorylation of dAdo and dGuo as well as dCyd and arabinofuranosylcvtosine.
arabinofuranosylcvtosine.
Deoxycytidine (dCyd) kinase (NTP:deoxycytidine 5'-phosphotransferase; EC 2.7.1.74) is responsible for the phosphorylation of several deoxyribonucleosides and their analogs. The enzyme has been shown to have broad substrate specificity for dAdo and dGuo as well as for dCyd (1) (2) (3) (4) (5) (6) (7) and plays a physiologic role in the maintenance of normal deoxyribonucleotide pools. dCyd kinase is also a key enzyme in the phosphorylation of a variety of antineoplastic and antiviral nucleoside analogs including 1-f3-D-arabinofuranosylcytosine ("cytosine arabinoside," araC) (8, 9) and dideoxycytidine (ddCyd) (10) , and deficiency of dCyd kinase activity mediates resistance to these drugs. The enzyme is allosterically regulated by several deoxyribonucleotides and preferentially uses ATP as a phosphate donor for the phosphorylation of dCyd (1) (2) (3) (4) (5) (6) (7) 11) . A more detailed understanding ofthe structure ofthis enzyme could therefore be ofuse in the design of new chemotherapeutic agents.
In comparison with other normal and leukemic lymphoid cells, human and murine thymocytes and T lymphoblasts have relatively high levels of dCyd kinase activity (12) (13) (14) , and it has been postulated that this increased enzyme activity plays a role in the sensitivity of these T cells to deoxyribonucleoside-induced cytotoxicity (15) . However, it has not been determined whether the variability in activity is due to alterations at the level of gene expression. In order to define the structure and regulation of dCyd kinase, we screened a MOLT-4 T-lymphoblast cDNA library with an oligonucleotide probe coding for a 12-amino acid peptide sequence obtained from purified protein. We have obtained a nearly full-length cDNA clone** encoding a 30.5-kDa protein that, when expressed in mammalian cells, has the kinetic properties and substrate specificity of the purified dCyd kinase protein. This sequence bears no relation to a previously reported dCyd kinase clone (16) .
MATERIALS AND METHODS
Cell Lines. Human T-lymphoblast (MOLT-4, Jurkat) and B-lymphoblast (MGL-8, GM558) cell lines were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum. Three cell lines deficient in dCyd kinase activity, including a murine L-cell line and two human CCRF-CEM T-lymphoblast lines selected in either araC or ddCyd, were graciously provided by Buddy Ullman. The parent cell line AB9228, deficient in hypoxanthine phosphoribosyltransferase (HPRT) activity, was mutagenized with N-methyl-Nnitroso-N'-nitroguanidine (3 gg/ml). The dCyd kinasedeficient clone Ara-C-8D was selected in 8 ,uM araC (10, 17) , whereas the ddCyd-resistant clone was selected in 50 ,gM ddCyd.
Purification and Amino Acid Sequencing of dCyd Kinase Protein. dCyd kinase was purified as described (7) (24) 
Protein Expression in Escherichia coli. The pET-3d bacterial expression vector was kindly provided by F. W. Studier (25) . The coding sequence of dCyd kinase cDNA was amplified by the polymerase chain reaction (PCR) technique using a 5' sense primer containing an Nco I restriction site (ACAC-CATGGCCACCCCGCCCAAGAGAAGCT) and a 3' reverse complement primer with a BamHI site (CACGGATCCTCA-CAAAGTACTCAAAAACTCT'l). Amplified DNA was subcloned into pET-3d and transformed into E. coli strain BL21(DE3). The pET-3d vector alone was used as a control. Protein in bacterial lysate supernatants from centrifugation at 48,000 x g was analyzed by SDS/PAGE and by radiochemical assays for dCyd kinase activity (7) .
Protein Expression in Mammalian Cells. The pDCK3B1A construct containing the 2.5-kb cDNA insert obtained from the CCRF-CEM library was cotransfected with the pSV2neo (26) vector into dCyd kinase-deficient murine L cells by standard techniques (27) . L cells were also transfected with pSV2neo and an unrelated control insert (pAKE) obtained from the same library. Transfected cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum for 72 hr. The neomycin analog G418 was then added at 1 mg/ml. After 3 weeks, clusters of one to three colonies were expanded and assayed for dCyd kinase activity.
RESULTS
Isolation of dCyd Kinase cDNA. Of the tryptic peptides generated from -30 pmol of purified dCyd kinase, three could be sequenced. The amino acid sequences obtained were Trp-Cys-Asn-Val-Gln-Ser-Thr-Gln-Asp-Glu-Phe-GluGlu, Ile-Tyr-Leu-Arg, and Ala-Glu-Lys-Pro-Val-Leu-PhePhe-Glu. Based on 12 amino acids from the first peptide, a 35-base oligomer was synthesized using a combination of codon-usage bias and deoxyinosine substitution at degenerate positions (22) (TGCAACGTICAITCCACICAIGAT-GAITTCGAIGA). A 2.2-kb cDNA clone was isolated from a MOLT-4 cDNA Agtll library on the basis of hybridization to this oligomer and was found to contain nucleotide sequence coding for all three peptides. Five additional cDNA clones ranging in size from 850 to 2460 base pairs (bp) were isolated from a CCRF-CEM cDNA expression library, and the full sequence of the largest clone, pDCK3B1A, was determined (Fig. 1) .
The cDNA includes a 780-bp open reading frame encoding a protein with a predicted size of 30.5 kDa. There is a single potential N-linked glycosylation site at amino acid 148, and amino acids 28-34 (Gly-Asn-Ile-Ala-Ala-Gly-Lys) approximate the consensus nucleotide binding site Gly-Xaa-XaaGly-Xaa-Gly-Lys (11). The cDNA clone also contains a 160-bp G+C-rich 5' untranslated region and 1360 bp of A+T-rich 3' noncoding sequence containing three potential polyadenylylation signals, the last located 18 bp from a poly(A) region (Fig. 1) .
Bacterial Expression of dCyd Kinase. Isopropyl j-Dthiogalactopyranoside induction of T7 RNA polymerase activity in the pET-3d expression vector containing the cDNA insert resulted in the production of a protein of 30.5-kDa subunit molecular mass as seen on Coomassie-blue staining of SDS/polyacrylamide gels, whereas no distinct band was visible in this region for bacteria transformed with vector alone (Fig. 2) . These data confirm that the dCyd kinase cDNA encodes a protein of the predicted subunit molecular mass.
Lysates of bacteria containing the pET-3d vector with or without insert were assayed for dCyd kinase activity. In the lysates from bacteria transformed with vector alone, dCyd kinase activity was <2-fold above background. In contrast, there was a 40-fold increase in dCyd kinase activity above background in lysates from bacteria transformed with the expression vector containing the dCyd kinase cDNA insert.
Murine L-Cell Expression of dCyd Kinase Activity. Table 1 shows the results of assays for deoxynucleoside-phosphorylating ability in extracts from transfected murine L cells. Using dCyd, dAdo, and dGuo as substrates, the phosphorylating activities of lysates from cells transfected with the dCyd kinase cDNA construct were 427-, 14-, and 148-fold greater than control values, respectively. These results show that the protein encoded by this cDNA phosphorylates all three deoxyribonucleosides. To verify that the kinetics ofthis protein are similar to those of the purified dCyd kinase, the apparent Km for dCyd was determined on a desalted cell extract and was found to be 1.0 ,uM. This value is very similar to apparent Km values that we and others have previously reported for the enzyme (5-7).
Northern Blot Analysis. The dCyd kinase cDNA probe detected a single band of 2.8 kb for all lymphoid cell lines examined (Figs. 3 and 4) . There was 5-10 times more dCyd kinase mRNA in MOLT-4 and Jurkat T lymphoblasts than in two B-lymphoblast lines (Fig. 3) .
The levels of dCyd kinase mRNA were also determined in CCRF-CEM T lymphoblasts deficient in dCyd kinase activity. dCyd kinase mRNA levels in wild-type CCRF-CEM cells from our laboratory (Fig. 4, lane 4) and the HPRT-deficient parent CCRF-CEM line from Ullman's laboratory (Fig. 4 lane 1) were comparable to levels in other T-lymphoblast cell lines (Fig. 3 ). In contrast, the level of dCyd kinase mRNA in the Ara-C-8D cells (Fig. 4, lane 2) was significantly decreased and that in ddCyd-resistant cells (Fig. 4, lane 3) was barely detectable. These data suggest that the functional dCyd kinase deficiency found in the resistant cell lines may be due to alterations in dCyd kinase mRNA expression.
DISCUSSION
dCyd kinase activity plays an integral role in the phosphorylation of three deoxyribonucleoside substrates and a broad spectrum of deoxyribonucleoside analogs used as antineoplastic and antiviral compounds. However, the low abundance and instability of this protein have hampered its purification and have led to disparate conclusions regarding its size and substrate specificity. We have definitively demonstrated that dCyd kinase activity resides in a protein of 30.5-kDa subunit molecular mass and that this protein is capable of phosphorylating dAdo and dGuo as well as dCyd. These data are in accord with previous reports on the purified enzyme by ourselves (7) and others (5) . However, they conflict with recent data on affinity-purified enzyme from T The blot reprobed with f3-actin cDNA.
lymphoblasts indicating that dCyd kinase is a 59.3-kDa monomer with proteolytic degradation products of 30 and 33 kDa (28 (31, 32) . These observations led to the conclusion that a single dCyd kinase catalyzed the phosphorylation of all three deoxyribonucleosides in intact cells. Our data are consistent with this hypothesis and provide direct evidence for an alteration in the expression of dCyd kinase mRNA in both araC-and ddCyd-resistant cells.
The phosphorylation of dAdo and dGuo to their corresponding monophosphates by dCyd kinase is the rate-limiting first step in the synthesis of dATP and dGTP, which serve as precursors of DNA synthesis and, at higher concentrations, as inhibitors of the enzyme ribonucleotide reductase (EC 1.17.4.1). Both dAdo and dGuo have been implicated in the pathogenesis of the immunodeficiency syndromes associated with adenosine deaminase deficiency (15, 33) and purine nucleoside phosphorylase deficiency (34), respectively. Cultured human T lymphoblasts and thymocytes are far more susceptible to dATP or dGTP accumulation in the presence of dAdo or dGuo than are B lymphoblasts or more mature lymphoid cells (35) (36) (37) , and it has been hypothesized that dATP or dGTP accumulation is the mechanism of cytotoxicity for T-cell precursors in these disorders. This accumulation could occur as a consequence ofincreased dCyd kinase activity, decreased deoxyribonucleotide degradatory activity, or a combination of these factors (15) . dCyd kinase activity in T-lymphoblast and thymocyte cell extracts is increased relative to other lymphoid cells (12) (13) (14) , but whether this difference in activity is mediated at the level of gene expression or via modulation of enzyme activity by intracellular metabolites has not been clarified. Our data clearly indicate that the steady-state levels of mRNA for dCyd kinase are 5-to 10-fold higher in T lymphoblasts than in B lymphoblasts and strongly suggest that the differences in activity are due at least in part to increased expression of the gene or to increased stability of its mRNA in T lymphoblasts. This tissue-specific expression of dCyd kinase may partially explain the selective T-cell toxicity observed in adenosine deaminase and purine nucleoside phosphorylase deficiency.
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